Author:
Sorensen A Gregory,Batchelor Tracy T,Wen Patrick Y,Zhang Wei-Ting,Jain Rakesh K
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Reference32 articles.
1. The Online NewsHour (online 28 March 2007) Extended interview: Janet Woodcock discusses cancer biomarkers. [
http://www.pbs.org/newshour/bb/health/jan-june07/cancerwoodcock_ 03-28.html
] (accessed 28 April 2007)
2. Woodcock J (online 5 May 2005) The Critical Path initiative: one year later. [
http://www.fda.gov/cder/regulatory/medImaging/woodcock.ppt
] (accessed 28 April 2007)
3. Johnson JR et al. (2003) End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 21: 1404–1411
4. Macdonald DR et al. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277–1280
5. Brada M and Yung WK (2000) Clinical trial end points in malignant glioma: need for effective trial design strategy. Semin Oncol 27: 11–19
Cited by
170 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献